Intellectual Property

  • February 12, 2026

    Colo. Builder Says Ex-Assistant Stole Trade Secrets

    The former executive assistant of a high-end Denver homebuilder misappropriated confidential vendor and customer information to pursue a competing business in violation of federal and state trade secrets laws, the construction company told a Colorado federal court.

  • February 12, 2026

    Inventor Says Claims Against Baker Botts Atty Should Remain

    Inventor Leigh M. Rothschild and Analytical Technologies LLC are taking issue with a Florida federal judge recommending tossing some claims in their lawsuit alleging a patent attorney defamed him, arguing Rothschild's words should be considered commercial speech.

  • February 12, 2026

    Astellas Gets $120M From Zydus In Bladder Drug Deal

    Generic-drug maker Zydus Pharmaceuticals has inked a $120 million deal to end a lawsuit accusing it of infringing Astellas Pharma Inc. patents covering bladder drug Myrbetriq, just two days after Lupin Pharmaceuticals made a similar deal.

  • February 12, 2026

    IP Firms Are Navigating AI Era With Range Of Guardrails

    Intellectual property law firms are taking various approaches to implementing artificial intelligence into their professional routines, with some developing their own tools, others limiting what external AI platforms that lawyers can access and one firm saying it has banned attorneys from using AI to draft legal briefs.

  • February 12, 2026

    InterDigital Says TCL, Hisense TVs Infringe Video Patents

    American firm InterDigital Inc. accused Chinese TV manufacturers Hisense Co. Ltd. and TCL Technology Group Corp. of selling televisions that infringe its video coding patents in separate federal district court suits as part of a worldwide litigation effort against the two companies.

  • February 12, 2026

    Regeneron, Samsung Bioepis Settle Eye Med Patent Claims

    Regeneron Pharmaceuticals Inc. and Samsung Bioepis Co. Ltd. have told a West Virginia federal court they reached an agreement to end patent infringement claims brought by Regeneron over a biosimilar of its eye medication Eylea.

  • February 12, 2026

    Intellectual Property Group Of The Year: Kirkland

    Kirkland & Ellis LLP attorneys notched landmark victories across copyright, patents and trade secrets, including the first U.S. decision to address whether training artificial intelligence systems with copyrighted content qualifies as fair use, earning the firm a spot among the 2025 Law360 Intellectual Property Groups of the Year.

  • February 12, 2026

    Chinese Co. Lacks Standing To Sue Hose Maker, Judge Says

    A Delaware federal judge has thrown out a suit from a Chinese company that wanted a declaration that its products didn't infringe a hose maker's patents after certain hoses were delisted on Amazon, saying the company lacked standing to sue.

  • February 11, 2026

    GoDaddy Challenges $170M Loss, Patent Owner Wants $370M

    GoDaddy is looking to nix its $170 million verdict loss in Express Mobile's lawsuit that accused the website hosting platform of willfully infringing patents related to creating websites while Express Mobile urged a Delaware federal court to increase its damages to $370 million, according to newly unsealed court filings.

  • February 11, 2026

    Fed. Circ. Backs $85M Patent Antitrust Verdict Against Ingevity

    The Federal Circuit on Wednesday declined to disturb a Delaware jury's $85 million antitrust verdict against Ingevity over it tying patent licenses to purchases of its automobile carbon filtering technology, rejecting the company's arguments that it was entitled to a certain statutory patent misuse defense.

  • February 11, 2026

    Design Patent Dissent Highlights Frustration Over Subjectivity

    Federal Circuit Judge Kimberly Moore's impassioned dissent to the court throwing out a design patent infringement suit captured how difficult it can be to frame comparisons, from a legal standard and based on differences in how people perceive the world, attorneys say.

  • February 11, 2026

    Judge Seeks Clarity On OpenAI's 'Project Giraffe' For IP Suit

    A New York federal magistrate judge on Wednesday ordered OpenAI to respond to questions about its "Project Giraffe," which plaintiffs suing over the company's use of copyrighted material in ChatGPT training describe as an effort to identify and block infringing outputs.

  • February 11, 2026

    Justices Urged To Restore $181M Verdict Against AT&T, Nokia

    Finesse Wireless LLC has asked the U.S. Supreme Court to take up its challenge to the Federal Circuit's decision wiping out a $181 million verdict against AT&T and Nokia, saying it's part of a long trend of the circuit court not respecting jury verdicts.

  • February 11, 2026

    CoStar Digs In On Quinn Emanuel DQ Bid In CREXi IP Suit

    CoStar doubled down on its efforts to disqualify Quinn Emanuel Urquhart & Sullivan LLP counsel from representing rival CREXi amid copyright infringement litigation in California federal court, reiterating that it's not bound by a conflict waiver signed by a company CoStar later acquired.

  • February 11, 2026

    Blockbuster's TM Legacy Tested By Dispute Over Deer Feed

    Once a titan in U.S. retail, the Blockbuster brand is embroiled in an unexpected trademark battle with a Mississippi-based animal feed company that it accuses of trying to exploit the legacy of the once-ubiquitous video rental chain.

  • February 11, 2026

    9th Circ. Mulls DMCA Claim Against Microsoft And OpenAI

    A group of software developers Wednesday urged the Ninth Circuit to revive their claim that Microsoft, GitHub and OpenAI violated the Digital Millennium Copyright Act by stripping copyright management information from the developers' open source code, which the companies then used to develop the artificial intelligence tools for Microsoft's Copilot software.

  • February 11, 2026

    Calif. Atty Wins $25K Fee Sanction Over AI Errors

    A California federal court has ordered $25,000 in fee sanctions for a litigator representing a mobile app platform in a copyright and contract suit as reimbursement for work he said went into responding to an error-ridden motion and further resulting motion practice.

  • February 11, 2026

    Lighting Co. Signify Nets $411K Verdict In Patent Case

    A Nevada federal jury found that lighting company Lepro owes nearly $411,000 in a suit brought by rival Signify over LED technology patents after finding the remaining three patents before the jury were infringed.

  • February 11, 2026

    Estee Lauder Hits Walmart With TM Suit Alleging Copycats

    Estee Lauder hit Walmart with a trademark infringement suit in California federal court Monday, accusing it of hawking copycat versions of its luxury personal care products, cosmetics and fragrance collections sold under popular brands including Clinique, La Mer and Tom Ford. 

  • February 11, 2026

    Squires Spurns 16 Petitions, Grants 6 In Latest Bulk Order

    U.S. Patent and Trademark Office Director John Squires' latest summary decision instituted six petitions for America Invents Act patent challenges and denied 16 others, bringing his total of rejected petitions to 266.

  • February 11, 2026

    Miami World Cup Counsel Share Look At Prep Work, Impact

    Counsel representing the FIFA World Cup's Miami Host Committee gave Law360 an inside look at their multifaceted work preparing for the upcoming event, which organizers say could have the economic impact of multiple Super Bowls.

  • February 11, 2026

    Supreme Court Sets April Argument For 'Skinny Label' Case

    The U.S. Supreme Court has set an April 29 date for oral arguments in Hikma Pharmaceutical Inc.'s appeal of a decision that revived a patent case over its "skinny label" on a generic heart drug.

  • February 11, 2026

    7th Circ. Mulls Expiration Date Of Teva, Eli Lilly Patent Deal

    Seventh Circuit judges Wednesday pressed counsel for Teva Pharmaceuticals USA Inc. to address how long a settlement under which Eli Lilly & Co. agreed not to block the approval and marketing of Teva's generic version of its osteoporosis drug Forteo could reasonably remain in effect, given Teva's drug wasn't ready for market until years after the underlying patent dispute.

  • February 11, 2026

    Shkreli Can't Add Wu-Tang Members To Fight With Crypto Co.

    "Pharma Bro" Martin Shkreli can't drag two members of the Wu-Tang Clan hip-hop group into a suit brought by a crypto firm that claims Shkreli improperly retained copies of an album that it bought the rights to, a New York federal judge ruled on Wednesday.

  • February 11, 2026

    MrBeast, Ex-IT Worker Near Deal In Trade Secret Theft Dispute

    YouTube star MrBeast's media company has told a North Carolina federal judge it has reached a settlement in principle to resolve its lawsuit accusing a former IT contractor of downloading thousands of confidential company documents ahead of his firing and leaving behind hidden cameras throughout the company's offices.

Expert Analysis

  • Why Civil RICO Claims Are Gaining Traction With Plaintiffs

    Author Photo

    A Texas federal court's recent $71 million verdict in Point Bridge Capital v. Johnson demonstrates that, when used properly, civil lawsuits under the Racketeering Influenced and Corrupt Organizations Act can be a devastating weapon — and increasingly favorable for plaintiffs, says Akiva Shapiro at Gibson Dunn.

  • You're Out?: Rooftop Views Of Sports Games Raise IP Issues

    Author Photo

    A high-profile dispute between the Chicago Cubs and a rooftop business adjacent to Wrigley Field strikes at the intersection of sports, intellectual property and Chicago neighborhood tradition, highlighting novel questions that could significantly affect IP rights in the context of live events generally, say attorneys at Troutman Pepper.

  • 5 Key Steps To Prepare For Oral Arguments

    Author Photo

    Whether presenting oral arguments before the U.S. Supreme Court or a local county judge, effective preparation includes the same essential ingredients, from organizing arguments in blocks to maximizing the potential of mock exercises, says Allison Rocker at Baker McKenzie.

  • A Change In Big Pharma Response To FTC Delisting Warnings

    Author Photo

    While the effect of Federal Trade Commission notices to pharmaceutical companies about allegedly improper patent listings in the U.S. Food and Drug Administration's Orange Book had been de minimis through the end of last year, July data shows an increase in delistings, say Ratib Ali and Celia Lu at Competition Dynamics.

  • 9th Circ. Finding That NFTs Are Goods Will Change TM Law

    Author Photo

    The Ninth Circuit's recent ruling in Yuga Labs v. Ripps establishes that NFTs have real, commercial value under U.S. federal trademark law, a new legal precedent that may significantly influence intellectual property enforcement and marketplace policies regarding digital assets going forward, say attorneys at Wilson Elser.

  • Series

    Adapting To Private Practice: From Texas AUSA To BigLaw

    Author Photo

    As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.

  • Data Undermines USPTO's 'Settled Expectations' Doctrine

    Author Photo

    An analysis of inter partes review proceedings filed since 2012 appears to refute the U.S. Patent and Trademark Office's recent stance that patent owners develop a strong settled expectation that their patents will not be challenged after being in force for six years, say Jonathan DeFosse and Samuel Smith at Sheppard Mullin, and Kenzo Kasai at NGB Corp.

  • Advice For 1st-Gen Lawyers Entering The Legal Profession

    Author Photo

    Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.

  • Fed. Circ. In July: Instability In IPR Requirements

    Author Photo

    The Federal Circuit's decision in Shockwave v. Cardiovascular last month provided an important, albeit short-lived, clarification to the type of evidence that can be used in an inter partes review challenge, say attorneys at Knobbe Martens.

  • Structuring Noncompetes In License And Collaboration Deals

    Author Photo

    As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.

  • Series

    Coaching Cheerleading Makes Me A Better Lawyer

    Author Photo

    At first glance, cheerleading and litigation may seem like worlds apart, but both require precision, adaptability, leadership and the ability to stay composed under pressure — all of which have sharpened how I approach my work in the emotionally complex world of mass torts and personal injury, says Rashanda Bruce at Robins Kaplan.

  • 7 Ways To Fetch Patents In The World Of Working Animals

    Author Photo

    Though developers rarely file patents related to working animals, and animal training techniques are generally considered unpatentable, certain aspects of training and developing animals may be ripe for patent protection, say Matthew Avery at Baker Botts, Makenzi Galvan at Perkins Coie and Lute Yang at Orrick.

  • Ruling Puts 11th Circ. At Odds With Bankruptcy Courts

    Author Photo

    While an Eleventh Circuit majority recently found in BenShot v. 2 Monkey Trading and Lucky Shot USA that corporate debtors, like individuals, face certain exceptions to discharge under a nonconsensual Subchapter V plan, the ruling not only reverses the lower court, but opposes the holdings of many other bankruptcy courts, say attorneys at McDermott.

  • Series

    Law School's Missed Lessons: How To Make A Deal

    Author Photo

    Preparing lawyers for the nuances of a transactional practice is not a strong suit for most law schools, but, in practice, there are six principles that can help young M&A lawyers become seasoned, trusted deal advisers, says Chuck Morton at Venable.

  • A New IP Game Plan For College Football Players

    Author Photo

    For college stars navigating their first season under the newly implemented settlement in House v. NCAA and new NFL recruits, securing trademark rights isn't just a savvy business move — it's essential for building and protecting a personal brand that can outlast their playing days, says Ryan Loveless at CM Law.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.